Bulk Manufacturer of Controlled Substances Application: Bulk Manufacturer of Marihuana: GGGYI LLC, 11328-11329 [2021-03754]
Download as PDF
<![CDATA[
11328
Federal Register / Vol. 86, No. 35 / Wednesday, February 24, 2021 / Notices
Anthropology. The human remains are
a shovel shaped incisor with a groove
between the enamel and the tooth root.
No known individual was identified. No
associated funerary objects are present.
Museum records indicate that the
Buick Camp Site represents a High
Plains Upper Republican occupation.
Radiocarbon analysis dates the Buick
Camp Site to 664–770 A.D., which
corresponds to the Plains Woodland
Period. Archeologists identify the Upper
Republican culture as ancestral Pawnee.
Elbert County is within the cultural
landscape of the Pawnee Nation. Based
on archeological and historical
evidence, the Buick Camp Site was
situated in an area where bison were
harvested at least bi-annually.
Determinations Made by the University
of Denver Museum of Anthropology
Officials of the University of Denver
Museum of Anthropology have
determined that:
• Pursuant to 25 U.S.C. 3001(9), the
human remains described in this notice
represent the physical remains of one
individual of Native American ancestry.
• Pursuant to 25 U.S.C. 3001(2), there
is a relationship of shared group
identity that can be reasonably traced
between the Native American human
remains and the Pawnee Nation of
Oklahoma.
khammond on DSKJM1Z7X2PROD with NOTICES
Additional Requestors and Disposition
Lineal descendants or representatives
of any Indian Tribe or Native Hawaiian
organization not identified in this notice
that wish to request transfer of control
of these human remains should submit
a written request with information in
support of the request to Anne Amati,
University of Denver Museum of
Anthropology, 2000 E Asbury Avenue,
Sturm Hall 146, Denver, CO 80208,
telephone (303) 871–2687, email
anne.amati@du.edu, by March 26, 2021.
After that date, if no additional
requestors have come forward, transfer
of control of the human remains to the
Pawnee Nation of Oklahoma may
proceed.
The University of Denver Museum of
Anthropology is responsible for
notifying the Pawnee Nation of
Oklahoma and The Invited Tribes that
this notice has been published.
Dated: February 5, 2021.
Melanie O’Brien,
Manager, National NAGPRA Program.
[FR Doc. 2021–03716 Filed 2–23–21; 8:45 am]
BILLING CODE 4312–52–P
VerDate Sep<11>2014
17:21 Feb 23, 2021
Jkt 253001
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–797]
Bulk Manufacturer of Controlled
Substances Application: Bulk
Manufacturer of Marihuana: AJC
Industries, Inc.
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
The Drug Enforcement
Administration (DEA) is providing
notice of an application it has received
from an entity applying to be registered
to manufacture in bulk basic class(es) of
controlled substances listed in schedule
I. DEA intends to evaluate this and other
pending applications according to its
regulations governing the program of
growing marihuana for scientific and
medical research under DEA
registration.
SUMMARY:
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefor, may file written
comments on or objections to the
issuance of the proposed registration on
or before April 26, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW 8701
Morrissette Drive, Springfield, Virginia
22152. To ensure proper handling of
comments, please reference Docket No.
DEA–797 in all correspondence,
including attachments.
SUPPLEMENTARY INFORMATION: The
Controlled Substances Act (CSA)
prohibits the cultivation and
distribution of marihuana except by
persons who are registered under the
CSA to do so for lawful purposes. In
accordance with the purposes specified
in 21 CFR 1301.33(a), DEA is providing
notice that the entity identified below
has applied for registration as a bulk
manufacturer of schedule I controlled
substances. In response, registered bulk
manufacturers of the affected basic
class(es), and applicants therefor, may
file written comments on or objections
of the requested registration, as
provided in this notice. This notice does
not constitute any evaluation or
determination of the merits of the
application submitted.
The applicant plans to manufacture
bulk active pharmaceutical ingredients
(APIs) for product development and
distribution to DEA-registered
researchers. If the application for
registration is granted, the registrant
would not be authorized to conduct
DATES:
PO 00000
Frm 00112
Fmt 4703
Sfmt 4703
other activity under this registration
aside from those coincident activities
specifically authorized by DEA
regulations. DEA will evaluate the
application for registration as a bulk
manufacturer for compliance with all
applicable laws, treaties, and
regulations and to ensure adequate
safeguards against diversion are in
place.
As this applicant has applied to
become registered as a bulk
manufacturer of marihuana, the
application will be evaluated under the
criteria of 21 U.S.C. 823(a). DEA will
conduct this evaluation in the manner
described in the rule published at 85 FR
82333 on December 18, 2020, and
reflected in DEA regulations at 21 CFR
part 1318.
In accordance with 21 CFR
1301.33(a), DEA is providing notice that
on January 14, 2021, AJC Industries Inc.,
19469 County Road H, Ordway,
Colorado 81063–9739, applied to be
registered as a bulk manufacturer of the
following basic class(es) of controlled
substances:
Controlled
substance
Marihuana extraxt ...........
Marihuana .......................
Drug
code
Schedule
7350
7360
I
I
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021–03755 Filed 2–23–21; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–794]
Bulk Manufacturer of Controlled
Substances Application: Bulk
Manufacturer of Marihuana: GGGYI
LLC
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
The Drug Enforcement
Administration (DEA) is providing
notice of an application it has received
from an entity applying to be registered
to manufacture in bulk basic class(es) of
controlled substances listed in schedule
I. DEA intends to evaluate this and other
pending applications according to its
regulations governing the program of
growing marihuana for scientific and
medical research under DEA
registration.
SUMMARY:
E:\FR\FM\24FEN1.SGM
24FEN1
11329
Federal Register / Vol. 86, No. 35 / Wednesday, February 24, 2021 / Notices
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefor, may file written
comments on or objections to the
issuance of the proposed registration on
or before April 26, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW 8701
Morrissette Drive, Springfield, Virginia
22152. To ensure proper handling of
comments, please reference Docket No.
DEA–794 in all correspondence,
including attachments.
SUPPLEMENTARY INFORMATION: The
Controlled Substances Act (CSA)
prohibits the cultivation and
distribution of marihuana except by
persons who are registered under the
CSA to do so for lawful purposes. In
accordance with the purposes specified
in 21 CFR 1301.33(a), DEA is providing
notice that the entity identified below
has applied for registration as a bulk
manufacturer of schedule I controlled
substances. In response, registered bulk
manufacturers of the affected basic
class(es), and applicants therefor, may
file written comments on or objections
of the requested registration, as
provided in this notice. This notice does
not constitute any evaluation or
determination of the merits of the
application submitted.
The applicant plans to manufacture
bulk active pharmaceutical ingredients
(APIs) for product development and
distribution to DEA-registered
researchers. If the application for
registration is granted, the registrant
would not be authorized to conduct
other activity under this registration
aside from those coincident activities
DATES:
specifically authorized by DEA
regulations. DEA will evaluate the
application for registration as a bulk
manufacturer for compliance with all
applicable laws, treaties, and
regulations and to ensure adequate
safeguards against diversion are in
place.
As this applicant has applied to
become registered as a bulk
manufacturer of marihuana, the
application will be evaluated under the
criteria of 21 U.S.C. 823(a). DEA will
conduct this evaluation in the manner
described in the rule published at 85 FR
82333 on December 18, 2020, and
reflected in DEA regulations at 21 CFR
part 1318.
In accordance with 21 CFR
1301.33(a), DEA is providing notice that
on January 25, 2021, GGGYI LLC, 4168
South Drexel Boulevard 2A, Chicago,
Illinois 60653, applied to be registered
as a bulk manufacturer of the following
basic class(es) of controlled substances:
Controlled
substance
Drug
code
Marihuana Extract ...................
Marihuana ...............................
Tetrahydrocannabinols ...........
7350
7360
7370
Schedule
I
I
I
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021–03754 Filed 2–23–21; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–770]
Bulk Manufacturer of Controlled
Substances Application: Sigma Aldrich
Research Biochemicals, Inc
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Sigma Aldrich Research
Biochemicals, Inc, has applied to be
registered as a bulk manufacturer of
basic class(es) of controlled
substance(s). Refer to SUPPLEMENTARY
INFORMATION listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before April 26, 2021. Such persons
may also file a written request for a
hearing on the application on or before
April 26, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUMMARY:
In
accordance with 21 CFR 1301.33(a), this
is notice that on December 17, 2020,
Sigma Aldrich Research Biochemicals,
Inc, 400–600 Summit Drive, Burlington,
Massachusetts 01803, applied to be
registered as a bulk manufacturer of the
following basic classes of controlled
substances:
SUPPLEMENTARY INFORMATION:
khammond on DSKJM1Z7X2PROD with NOTICES
Controlled substance
Drug code
Cathinone ........................................................................................................................................................................
4-Methyl-N-Methylcathinone ............................................................................................................................................
Methaqualone ..................................................................................................................................................................
JWH-018 & AM678 ..........................................................................................................................................................
Lysergic Acid Diethylamide .............................................................................................................................................
Tetrahydrocannabinols ....................................................................................................................................................
Mescaline .........................................................................................................................................................................
3,4-Methylenedioxymethamphetamine ............................................................................................................................
Alpha-Methyltryptamine ...................................................................................................................................................
Dimethyltryptamine ..........................................................................................................................................................
5-Methoxy-N,N-Diisopropyltryptamine .............................................................................................................................
1-Benzylpiperazine ..........................................................................................................................................................
2-(2,5-Dimethoxyphenyl) Ethanamine .............................................................................................................................
3,4-Methylenedioxypyrovalerone .....................................................................................................................................
3,4-Methylenedioxy-N-Methylcathinone ..........................................................................................................................
Heroin ..............................................................................................................................................................................
Normorphine ....................................................................................................................................................................
Norlevorphanol ................................................................................................................................................................
Amphetamine ...................................................................................................................................................................
Methylphenidate ..............................................................................................................................................................
Nabilone ...........................................................................................................................................................................
Phencyclidine ...................................................................................................................................................................
Cocaine ............................................................................................................................................................................
VerDate Sep<11>2014
17:21 Feb 23, 2021
Jkt 253001
PO 00000
Frm 00113
Fmt 4703
Sfmt 4703
E:\FR\FM\24FEN1.SGM
24FEN1
1235
1248
2565
7118
7315
7370
7381
7405
7432
7435
7439
7493
7517
7535
7540
9200
9313
9634
1100
1724
7379
7471
9041
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
]]>Agencies
[Federal Register Volume 86, Number 35 (Wednesday, February 24, 2021)]
[Notices]
[Pages 11328-11329]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-03754]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-794]
Bulk Manufacturer of Controlled Substances Application: Bulk
Manufacturer of Marihuana: GGGYI LLC
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: The Drug Enforcement Administration (DEA) is providing notice
of an application it has received from an entity applying to be
registered to manufacture in bulk basic class(es) of controlled
substances listed in schedule I. DEA intends to evaluate this and other
pending applications according to its regulations governing the program
of growing marihuana for scientific and medical research under DEA
registration.
[[Page 11329]]
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefor, may file written comments on or objections to
the issuance of the proposed registration on or before April 26, 2021.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW 8701
Morrissette Drive, Springfield, Virginia 22152. To ensure proper
handling of comments, please reference Docket No. DEA-794 in all
correspondence, including attachments.
SUPPLEMENTARY INFORMATION: The Controlled Substances Act (CSA)
prohibits the cultivation and distribution of marihuana except by
persons who are registered under the CSA to do so for lawful purposes.
In accordance with the purposes specified in 21 CFR 1301.33(a), DEA is
providing notice that the entity identified below has applied for
registration as a bulk manufacturer of schedule I controlled
substances. In response, registered bulk manufacturers of the affected
basic class(es), and applicants therefor, may file written comments on
or objections of the requested registration, as provided in this
notice. This notice does not constitute any evaluation or determination
of the merits of the application submitted.
The applicant plans to manufacture bulk active pharmaceutical
ingredients (APIs) for product development and distribution to DEA-
registered researchers. If the application for registration is granted,
the registrant would not be authorized to conduct other activity under
this registration aside from those coincident activities specifically
authorized by DEA regulations. DEA will evaluate the application for
registration as a bulk manufacturer for compliance with all applicable
laws, treaties, and regulations and to ensure adequate safeguards
against diversion are in place.
As this applicant has applied to become registered as a bulk
manufacturer of marihuana, the application will be evaluated under the
criteria of 21 U.S.C. 823(a). DEA will conduct this evaluation in the
manner described in the rule published at 85 FR 82333 on December 18,
2020, and reflected in DEA regulations at 21 CFR part 1318.
In accordance with 21 CFR 1301.33(a), DEA is providing notice that
on January 25, 2021, GGGYI LLC, 4168 South Drexel Boulevard 2A,
Chicago, Illinois 60653, applied to be registered as a bulk
manufacturer of the following basic class(es) of controlled substances:
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Marihuana Extract...................... 7350 I
Marihuana.............................. 7360 I
Tetrahydrocannabinols.................. 7370 I
------------------------------------------------------------------------
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021-03754 Filed 2-23-21; 8:45 am]
BILLING CODE 4410-09-P
